These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6697646)

  • 1. Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects.
    Frederiksen MC; Bowsher DJ; Ruo TI; Henthorn TK; Ts'ao CH; Green D; Atkinson AJ
    Clin Pharmacol Ther; 1984 Mar; 35(3):387-93. PubMed ID: 6697646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis.
    Fish SS; Pancorbo S; Berkseth R
    J Neurosurg; 1981 Jun; 54(6):736-9. PubMed ID: 7241183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of probenecid on the kinetics of epsilon-aminocaproic acid.
    Dvorchik BH; Katlic KL; Hayes AH; Eyster ME
    Clin Pharmacol Ther; 1980 Aug; 28(2):223-8. PubMed ID: 7398189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.
    Burchiel KJ; Hoffman JM; Bakay RA
    Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFFECT OF ε-AMINOCAPROIC ACID ON FIBRINOLYSIS IN PLASMA OF ASIAN ELEPHANTS (ELEPHAS MAXIMUS).
    Kaye S; Abou-Madi N; Fletcher DJ
    J Zoo Wildl Med; 2016 Jun; 47(2):397-404. PubMed ID: 27468009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epsilon-aminocaproic acid (EACA).
    Griffin JD; Ellman L
    Semin Thromb Hemost; 1978; 5(1):27-40. PubMed ID: 568312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory measures of hemostasis and fibrinolysis after intravenous administration of epsilon-aminocaproic acid in clinically normal horses and ponies.
    Heidmann P; Tornquist SJ; Qu A; Cebra CK
    Am J Vet Res; 2005 Feb; 66(2):313-8. PubMed ID: 15757133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
    Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
    Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired activation of the fibrinolytic system in children with Henoch-Schönlein purpura: beneficial effect of hydrocortisone plus Sigma-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis.
    Prandota J; Pankow-Prandota L; Kotecki L
    Am J Ther; 2001; 8(1):11-9. PubMed ID: 11304653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody to the epsilon-aminocaproic acid binding site on the kringle 4 region of human plasminogen that accelerates the activation of Glu1-plasminogen by urokinase.
    Cummings HS; Castellino FJ
    Arch Biochem Biophys; 1985 Feb; 236(2):612-8. PubMed ID: 2982318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis.
    Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ
    J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma proteinase inhibitor activity and hemostasis tests in children with nephrotic syndrome. Effect of prednisone alone and prednisone plus epsilon-aminocaproic acid treatment regimens: a preliminary report.
    Prandota J; Pankow-Prandota L; Kotecki L; Noga L
    Am J Ther; 2001; 8(2):97-107. PubMed ID: 11304663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epsilon-aminocaproic acid inhibition of fibrinolysis in vitro: should the 'therapeutic' concentration be reconsidered?
    Nielsen VG; Cankovic L; Steenwyk BL
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):35-9. PubMed ID: 17179824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of epsilon-aminocaproic acid in patients undergoing aortocoronary bypass surgery.
    Butterworth J; James RL; Lin Y; Prielipp RC; Hudspeth AS
    Anesthesiology; 1999 Jun; 90(6):1624-35. PubMed ID: 10360861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METHOD FOR DETERMINING EPSILON-AMINOCAPROIC ACID (EACA) IN BLOOD PLASMA, BASED ON THE ANTIFIBRINOLYTIC PROPERTIES OF THIS COMPOUND.
    WOLOSOWICZ N; NIEWIAROWSKI S; CZEREPKO K
    Thromb Diath Haemorrh; 1964 Jan; 10():309-16. PubMed ID: 14113373
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of tranexamic acid and ε-aminocaproic acid concentrations required to inhibit fibrinolysis in plasma of dogs and humans.
    Fletcher DJ; Blackstock KJ; Epstein K; Brainard BM
    Am J Vet Res; 2014 Aug; 75(8):731-8. PubMed ID: 25061704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A NEW METHOD OF THE ANALYSIS OF EPSILON-AMINOCAPROIC ACID (EACA) AND AMINOMETHYLCYCLOHEXANE CARBOXYLIC ACID (AMCHA), THE POTENT ANTIFIBRINOLYTIC AGENTS].
    TAKATA Y; TAKATA A; OKAMOTO U
    Nihon Seirigaku Zasshi; 1964 May; 26():281-5. PubMed ID: 14172890
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversal of shortened platelet survival in rats by the antifibrinolytic agent, epsilon aminocaproic acid.
    Winocour PD; Kinlough-Rathbone RL; Richardson M; Mustard JF
    J Clin Invest; 1983 Jan; 71(1):159-64. PubMed ID: 6848557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial plasmin activity with epsilon aminocaproic acid: temporal and regional heterogeneity.
    Reust DL; Reeves ST; Abernathy JH; Dixon JA; Gaillard WF; Mukherjee R; Koval CN; Stroud RE; Spinale FG
    Ann Thorac Surg; 2010 May; 89(5):1538-45. PubMed ID: 20417774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen.
    Markus G; DePasquale JL; Wissler FC
    J Biol Chem; 1978 Feb; 253(3):727-32. PubMed ID: 621200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.